{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:03:47Z","timestamp":1794002627231,"version":"4.8.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The objective was to compare the resolution of organ dysfunction, 28-day mortality, and biochemical markers in children with thrombocytopenia-associated multiple organ failure who received therapeutic plasma exchange versus no therapeutic plasma exchange.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Observational longitudinal cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>Nine U.S. PICUs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>Eighty-one children with sepsis-induced thrombocytopenia-associated multiple organ failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Therapeutic plasma exchange.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results:<\/jats:title>\n                    <jats:p>\n                      Adjusted relative risk for 28-day mortality was modeled using standard multivariate regression with propensity score weighting to reduce covariate confounding. Change from baseline Pediatric Logistic Organ Dysfunction scores between therapeutic plasma exchange and no therapeutic plasma exchange differed in temporal pattern during the first week (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.009). By day 4, mean Pediatric Logistic Organ Dysfunction score declined by 7.9 points (95% CI, \u201310.8 to \u20135.1) in the therapeutic plasma exchange\u2013treated group compared with no change with no therapeutic plasma exchange. Use of therapeutic plasma exchange was associated with reduced 28-day mortality by multivariate analysis (adjusted relative risk, 0.45; 95% CI, 0.23\u20130.90;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.02) and by propensity score weighting (adjusted relative risk, 0.46; 95% CI, 0.22\u20130.97;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.04).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Therapeutic plasma exchange use in thrombocytopenia-associated multiple organ failure was associated with a decrease in organ dysfunction. After accounting for several risk factors, 28-day all-cause mortality was lower in children treated with therapeutic plasma exchange compared with those receiving no therapeutic plasma exchange. A multicenter randomized clinical trial is necessary to determine a causal relationship.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000003559","type":"journal-article","created":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T13:48:05Z","timestamp":1544190485000},"page":"e173-e181","source":"Crossref","is-referenced-by-count":81,"title":["Therapeutic Plasma Exchange in Children With Thrombocytopenia-Associated Multiple Organ Failure: The Thrombocytopenia-Associated Multiple Organ Failure Network Prospective Experience"],"prefix":"10.1097","volume":"47","author":[{"given":"James D.","family":"Fortenberry","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Emory University School of Medicine, Children\u2019s Healthcare of Atlanta at Egleston, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn R.","family":"Grunwell","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University School of Medicine, Children\u2019s Healthcare of Atlanta at Egleston, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh K.","family":"Aneja","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care Medicine, University of Pittsburgh School of Medicine, Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati Children\u2019s Medical Center, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Ohio State University School of Medicine, Nationwide Children\u2019s Hospital, Columbus, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Fleming","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University School of Medicine, Monroe Carell Jr Children\u2019s Hospital, Nashville, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rod","family":"Tarrago","sequence":"additional","affiliation":[{"name":"Department of Pediatric Intensive Care, Children\u2019s Hospital and Clinics of Minnesota, Minneapolis, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Buttram","sequence":"additional","affiliation":[{"name":"Department of Pediatric Critical Care, Phoenix Children\u2019s Hospital, Phoenix, AZ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Dalton","sequence":"additional","affiliation":[{"name":"Department of Pediatric Critical Care Medicine, Children\u2019s National Medical Center, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Michigan School of Medicine, C.S. Mott Children\u2019s Hospital, Ann Arbor, MI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk A.","family":"Easley","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Emory University, Rollins School of Public Health, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Knezevic","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Emory University, Rollins School of Public Health, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Emory University, Rollins School of Public Health, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Paden","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Emory University School of Medicine, Children\u2019s Healthcare of Atlanta at Egleston, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Carcillo","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Critical Care Medicine, University of Pittsburgh School of Medicine, Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230728","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/PCC.0b013e3182917fad","article-title":"Trends in the epidemiology of pediatric severe sepsis.","volume":"14","author":"Hartman","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"R2-20230728","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/PCC.0000000000000254","article-title":"Pediatric severe sepsis: Current trends and outcomes from the Pediatric Health Information Systems database.","volume":"15","author":"Ruth","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R3-20230728","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/PCC.0000000000001044","article-title":"Multiple organ dysfunction syndrome: A challenge for the pediatric critical care community.","volume":"18","author":"Tamburro","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"R4-20230728","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1164\/rccm.200207-682OC","article-title":"The epidemiology of severe sepsis in children in the United States.","volume":"167","author":"Watson","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-20230728","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/cc5064","article-title":"Bench-to-bedside review: Thrombocytopenia-associated multiple organ failure\u2013a newly appreciated syndrome in the critically ill.","volume":"10","author":"Nguyen","year":"2006","journal-title":"Crit Care"},{"key":"R6-20230728","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/01.CCM.0000257468.75474.D4","article-title":"Understanding the role of von Willebrand factor and its cleaving protease ADAM TS13 in the pathophysiology of critical illness.","volume":"8","author":"Nguyen","year":"2007","journal-title":"Pediatr Crit Care Med"},{"key":"R7-20230728","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ccc.2015.06.004","article-title":"Thrombocytopenia-associated multiple organ failure and acute kidney injury.","volume":"31","author":"Nguyen","year":"2015","journal-title":"Crit Care Clin"},{"key":"R8-20230728","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/PCC.0000000000001122","article-title":"Three hypothetical inflammation pathobiology phenotypes and pediatric sepsis-induced multiple organ failure outcome.","volume":"18","author":"Carcillo","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"R9-20230728","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/PCC.0000000000001052","article-title":"Pathophysiology of pediatric multiple organ dysfunction syndrome.","volume":"18","author":"Carcillo","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"R10-20230728","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1097\/CCM.0000000000001852","article-title":"Pediatric sepsis biomarker risk model-II: Redefining the pediatric sepsis biomarker risk model with septic shock phenotype.","volume":"44","author":"Wong","year":"2016","journal-title":"Crit Care Med"},{"key":"R11-20230728","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM199108083250605","article-title":"Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.","volume":"325","author":"Bell","year":"1991","journal-title":"N Engl J Med"},{"key":"R12-20230728","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation.","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R13-20230728","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood.V98.6.1765","article-title":"Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: A study of 111 cases.","volume":"98","author":"Veyradier","year":"2001","journal-title":"Blood"},{"key":"R14-20230728","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2141.2004.05009.x","article-title":"Plasma levels of von Willebrand factor regulate ADAMTS-13, its major cleaving protease.","volume":"126","author":"Mannucci","year":"2004","journal-title":"Br J Haematol"},{"key":"R15-20230728","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2141.2004.05217.x","article-title":"Von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura.","volume":"127","author":"Peyvandi","year":"2004","journal-title":"Br J Haematol"},{"key":"R16-20230728","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2004-01-0107","article-title":"Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow.","volume":"104","author":"Bernardo","year":"2004","journal-title":"Blood"},{"key":"R17-20230728","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2004-06-2096","article-title":"Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: In vitro inhibition of ADAMTS13 activity by hemoglobin.","volume":"105","author":"Studt","year":"2005","journal-title":"Blood"},{"key":"R18-20230728","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood-2009-03-213967","article-title":"Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13.","volume":"115","author":"Chen","year":"2010","journal-title":"Blood"},{"key":"R19-20230728","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1182\/blood-2004-03-1101","article-title":"Proteolytic inactivation of ADAMTS13 by thrombin and plasmin.","volume":"105","author":"Crawley","year":"2005","journal-title":"Blood"},{"key":"R20-20230728","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2005-03-1087","article-title":"Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: Its correlation with development of renal failure.","volume":"107","author":"Ono","year":"2006","journal-title":"Blood"},{"key":"R21-20230728","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"R22-20230728","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International Pediatric Sepsis Consensus Conference: Definitions for sepsis and organ dysfunction in pediatrics.","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"R23-20230728","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1097\/CCM.0b013e318186aa49","article-title":"Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure.","volume":"36","author":"Nguyen","year":"2008","journal-title":"Crit Care Med"},{"key":"R25-20230728","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data.","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R26-20230728","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2015.11.029","article-title":"Clinical variables and Staphylococcus aureus virulence factors associated with venous thromboembolism in children.","volume":"138","author":"Carpenter","year":"2016","journal-title":"Thromb Res"},{"key":"R27-20230728","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1086\/428573","article-title":"Purpura fulminans due to Staphylococcus aureus.","volume":"40","author":"Kravitz","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R28-20230728","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1097\/CCM.0b013e318260c7f8","article-title":"Coinfection with Staphylococcus aureus increases risk of severe coagulopathy in critically ill children with influenza A (H1N1) virus infection.","volume":"40","author":"Nguyen","year":"2012","journal-title":"Crit Care Med"},{"key":"R29-20230728","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00130478-200107000-00001","article-title":"Microvascular thrombosis in pediatric multiple organ failure: Is it a therapeutic target?","volume":"2","author":"Nguyen","year":"2001","journal-title":"Pediatr Crit Care Med"},{"key":"R30-20230728","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PCC.0000000000000372","article-title":"Therapeutic plasma exchange as a strategy to reverse Multiple Organ Dysfunction Syndrome in patients receiving extracorporeal life support.","volume":"16","author":"Nguyen","year":"2015","journal-title":"Pediatr Crit Care Med"},{"key":"R31-20230728","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ccc.2012.04.009","article-title":"The role of plasmapheresis in critical illness.","volume":"28","author":"Nguyen","year":"2012","journal-title":"Crit Care Clin"},{"key":"R32-20230728","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/039139880502800506","article-title":"Plasma therapies in thrombotic syndromes.","volume":"28","author":"Nguyen","year":"2005","journal-title":"Int J Artif Organs"},{"key":"R33-20230728","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.pcl.2017.06.007","article-title":"Rationale for adjunctive therapies for pediatric sepsis induced multiple organ failure.","volume":"64","author":"Podd","year":"2017","journal-title":"Pediatr Clin North Am"},{"key":"R34-20230728","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1097\/PCC.0000000000000227","article-title":"Use of therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure in the Turkish thrombocytopenia-associated multiple organ failure network.","volume":"15","author":"Sevketoglu","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R35-20230728","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1097\/01.CCM.0000064742.00981.14","article-title":"Plasma exchange as rescue therapy in multiple organ failure including acute renal failure.","volume":"31","author":"Stegmayr","year":"2003","journal-title":"Crit Care Med"},{"key":"R36-20230728","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: The seventh special issue.","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"key":"R37-20230728","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00134-002-1410-7","article-title":"Plasmapheresis in severe sepsis and septic shock: A prospective, randomised, controlled trial.","volume":"28","author":"Busund","year":"2002","journal-title":"Intensive Care Med"},{"key":"R38-20230728","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1097\/CCM.0b013e31828cf412","article-title":"Blood purification and mortality in sepsis: A meta-analysis of randomized trials.","volume":"41","author":"Zhou","year":"2013","journal-title":"Crit Care Med"},{"key":"R39-20230728","doi-asserted-by":"crossref","first-page":"R52","DOI":"10.1186\/cc11256","article-title":"Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction syndrome\/macrophage activation syndrome: What is the treatment?","volume":"16","author":"Demirkol","year":"2012","journal-title":"Crit Care"},{"key":"R40-20230728","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3324\/haematol.10262","article-title":"Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis.","volume":"92","author":"Nguyen","year":"2007","journal-title":"Haematologica"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003246-201903000-00033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T07:29:48Z","timestamp":1690529388000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003246-201903000-00033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000003559","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}